APP gene related symptoms and diseases

All the information presented here about the APP gene and its related diseases, symptoms, and test panels has been aggregated from the following public sources: OMIM,NCBIGENE,HGNC,ORPHANET, Mendelian Rare Disease Search Engine.

Top 5 symptoms and clinical features associated to APP gene

Symptoms // Phenotype % Cases
Dementia Common - Between 50% and 80% cases
Stroke Common - Between 50% and 80% cases
Seizures Uncommon - Between 30% and 50% cases
Cerebral hemorrhage Uncommon - Between 30% and 50% cases
Behavioral abnormality Uncommon - Between 30% and 50% cases

Other less frequent symptoms and clinical features

Patients with APP gene alterations may also develop some of the following symptoms and phenotypes:
  • Not very common - Between 30% and 50% cases

  • Myoclonus
  • Intellectual disability
  • Neurofibrillary tangles
  • Alzheimer disease
  • Memory impairment
  • Mental deterioration
  • Rarely - Less than 30% cases

  • Parkinsonism
  • Encephalopathy

And 54 more phenotypes, you can get all of them using our tools for rare diseases.

Rare diseases associated to APP gene

Here you will find a list of rare diseases related to the APP. You can also use our tool to get a more accurate diagnosis based on your current symptoms.


ABETA AMYLOIDOSIS, DUTCH TYPE

Alternate names

ABETA AMYLOIDOSIS, DUTCH TYPE Is also known as hchwad, amyloidosis, hereditary, with cerebral hemorrhage, dutch variant, hereditary cerebral hemorrhage with amyloidosis, dutch type, cerebral amyloid angiopathy, app-related, iowa variant, cerebral amyloid angiopathy, app-related, italian variant, hchwa, dut

Description

Hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D) is a form of HCHWA (see this term), a group of familial central nervous system disorders, characterized by severe cerebral amyloid angiopathy (CAA), hemorrhagic and non-hemorrhagic strokes and dementia.

Most common symptoms of ABETA AMYLOIDOSIS, DUTCH TYPE

  • Seizures
  • Cognitive impairment
  • Hypertension
  • Behavioral abnormality
  • Headache


More info about ABETA AMYLOIDOSIS, DUTCH TYPE

SOURCES: ORPHANET OMIM

ALZHEIMER DISEASE; AD

Alternate names

ALZHEIMER DISEASE; AD Is also known as presenile and senile dementia

Description

Alzheimer disease is the most common form of progressive dementia in the elderly. It is a neurodegenerative disorder characterized by the neuropathologic findings of intracellular neurofibrillary tangles (NFT) and extracellular amyloid plaques that accumulate in vulnerable brain regions (Sennvik et al., 2000). Terry and Davies (1980) pointed out that the 'presenile' form, with onset before age 65, is identical to the most common form of late-onset or 'senile' dementia, and suggested the term 'senile dementia of the Alzheimer type' (SDAT).Haines (1991) reviewed the genetics of AD. Selkoe (1996) reviewed the pathophysiology, chromosomal loci, and pathogenetic mechanisms of Alzheimer disease. Theuns and Van Broeckhoven (2000) reviewed the transcriptional regulation of the genes involved in Alzheimer disease. Genetic Heterogeneity of Alzheimer DiseaseAlzheimer disease is a genetically heterogeneous disorder. See also AD2 (OMIM ), associated with the APOE*4 allele (OMIM ) on chromosome 19; AD3 (OMIM ), caused by mutation in the presenilin-1 gene (PSEN1 ) on 14q; and AD4 (OMIM ), caused by mutation in the PSEN2 gene (OMIM ) on 1q31.There is evidence for additional AD loci on other chromosomes; see AD5 (OMIM ) on 12p11, AD6 (OMIM ) on 10q24, AD7 (OMIM ) on 10p13, AD8 (OMIM ) on 20p, AD9 (OMIM ), associated with variation in the ABCA7 gene (OMIM ) on 19p13, AD10 (OMIM ) on 7q36, AD11 (OMIM ) on 9q22, AD12 (OMIM ) on 8p12-q22, AD13 (OMIM ) on 1q21, AD14 (OMIM ) on 1q25, AD15 (OMIM ) on 3q22-q24, AD16 (OMIM ) on Xq21.3, AD17 (OMIM ) on 6p21.2, and AD18 (OMIM ), associated with variation in the ADAM10 gene (OMIM ) on 15q21.Evidence also suggests that mitochondrial DNA polymorphisms may be risk factors in Alzheimer disease (OMIM ).Finally, there have been associations between AD and various polymorphisms in other genes, including alpha-2-macroglobulin (A2M; {103950.0005}), low density lipoprotein-related protein-1 (LRP1 ), the transferrin gene (TF ), the hemochromatosis gene (HFE ), the NOS3 gene (OMIM ), the vascular endothelial growth factor gene (VEGF ), the ABCA2 gene (OMIM ), and the TNF gene (OMIM ) (see MOLECULAR GENETICS).

Most common symptoms of ALZHEIMER DISEASE; AD

  • Intellectual disability
  • Seizures
  • Spasticity
  • Cognitive impairment
  • Edema


More info about ALZHEIMER DISEASE; AD

SOURCES: OMIM

EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE

Alternate names

EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE Is also known as early-onset familial autosomal dominant alzheimer disease, eofad, familial alzheimer disease

Description

Early-onset autosomal dominant Alzheimer disease (EOAD) is a progressive dementia with reduction of cognitive functions. EOAD presents the same phenotype as sporadic Alzheimer disease (AD) but has an early age of onset, usually before 60 years old.

Most common symptoms of EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE

  • Intellectual disability
  • Seizures
  • Ataxia
  • Hypertonia
  • Dementia


More info about EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE

SOURCES: ORPHANET

ABETAL34V AMYLOIDOSIS

Alternate names

ABETAL34V AMYLOIDOSIS Is also known as abetal34v-related amyloidosis, abeta amyloidosis, piedmont type, hchwa, piedmont type, hereditary cerebral hemorrhage with amyloidosis, piedmont type

Description

Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Piedmont type is a form of HCHWA (see this term) characterized by an age of onset between 50-70 years of age, recurrent lobar intracerebral hemorrhages and cognitive decline.

Most common symptoms of ABETAL34V AMYLOIDOSIS

  • Intellectual disability
  • Global developmental delay
  • Behavioral abnormality
  • Dementia
  • Stroke


More info about ABETAL34V AMYLOIDOSIS

SOURCES: ORPHANET

ABETA AMYLOIDOSIS, IOWA TYPE

Alternate names

ABETA AMYLOIDOSIS, IOWA TYPE Is also known as abetad23n amyloidosis, hchwa, iowa type, hereditary cerebral hemorrhage with amyloidosis, iowa type

Description

Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Iowa type is a form of HCHWA (see this term) characterized by age of onset between 50-66 years of age, memory impairment, myoclonic jerks, expressive dysphagia, short-stepped gait, personality changes and lobar intracerebral hemorrhages.

Most common symptoms of ABETA AMYLOIDOSIS, IOWA TYPE

  • Gait disturbance
  • Dysphagia
  • Behavioral abnormality
  • Dementia
  • Myoclonus


More info about ABETA AMYLOIDOSIS, IOWA TYPE

SOURCES: ORPHANET

ABETA AMYLOIDOSIS, ITALIAN TYPE

Alternate names

ABETA AMYLOIDOSIS, ITALIAN TYPE Is also known as hchwa, italian type, abetae22k amyloidosis, hereditary cerebral hemorrhage with amyloidosis, italian type

Description

Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Italian type is a form of HCHWA (see this term) characterized by an age of onset of 50 years of age, dementia and lobar intracerebral hemorrhage.

Most common symptoms of ABETA AMYLOIDOSIS, ITALIAN TYPE

  • Seizures
  • Dementia
  • Mental deterioration
  • Stroke
  • Coma


More info about ABETA AMYLOIDOSIS, ITALIAN TYPE

SOURCES: ORPHANET

ABETAA21G AMYLOIDOSIS

Alternate names

ABETAA21G AMYLOIDOSIS Is also known as hchwa, flemish type, abeta amyloidosis, flemish type, abetaa21g-related amyloidosis, hereditary cerebral hemorrhage with amyloidosis, flemish type

Description

Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Flemish type is a form of HCHWA (see this term) characterized by an age of onset of 45 years of age, progressive Alzheimer's disease-like dementia and lobar intracerebral hemorrhage in some patients.


More info about ABETAA21G AMYLOIDOSIS

SOURCES: ORPHANET

ABETA AMYLOIDOSIS, ARCTIC TYPE

Alternate names

ABETA AMYLOIDOSIS, ARCTIC TYPE Is also known as hereditary cerebral hemorrhage with amyloidosis, arctic type, abetae22g amyloidosis, hchwa, arctic type

Description

Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Arctic type is a form of HCHWA (see this term) characterized by an age of onset of 54-61 years and progressive Alzheimer's disease-like dementia, without intracerebral hemorrhages.

Most common symptoms of ABETA AMYLOIDOSIS, ARCTIC TYPE

  • Behavioral abnormality
  • Febrile seizures


More info about ABETA AMYLOIDOSIS, ARCTIC TYPE

SOURCES: ORPHANET


Potential gene panels for APP gene

MitoMet®Plus aCGH Analysis Panel

United States.

By Baylor Miraca Genetics Laboratories MitoMet®Plus aCGH Analysis that also includes the following genes: RGS9 RHO GRK1 RLBP1 RNASEL BCS1L RP1 RP2 RP9 RPE65

More info about this panel
United States.

ADmark® APP DNA Sequencing/Duplication Test Panel

United States.

By Athena Diagnostics Inc

This panel specifically test the APP gene.

More info about this panel
United States.

ADmark® Early Onset Alzheimer's Evaluation Panel

United States.

By Athena Diagnostics Inc ADmark® Early Onset Alzheimer's Evaluation that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
United States.

Dementia Panel

United States.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University Dementia that also includes the following genes: SORL1 TARDBP VCP FIG4 OPTN TREM2 CSF1R CHMP2B DCTN1 C9orf72

More info about this panel
United States.

APOE, APP, PSEN1, PSEN2. NextGeneDx.Complete sequencing by NGS Panel

Spain.

By Instituto de Medicina Genomica Instituto de Medicina Genomica APOE, APP, PSEN1, PSEN2. NextGeneDx.Complete sequencing by NGS that also includes the following genes: APOE APP PSEN1 PSEN2

More info about this panel
Spain.

APP. Complete sequencing Panel

Spain.

By Instituto de Medicina Genomica Instituto de Medicina Genomica

This panel specifically test the APP gene.

More info about this panel
Spain.

, APP. Complete sequencing Panel

Spain.

By Instituto de Medicina Genomica Instituto de Medicina Genomica

This panel specifically test the APP gene.

More info about this panel
Spain.

APP. MLPA testing Panel

Spain.

By Instituto de Medicina Genomica Instituto de Medicina Genomica

This panel specifically test the APP gene.

More info about this panel
Spain.

Alzheimer disease type 1 (sequence analysis of APP gene) Panel

Portugal.

By CGC Genetics

This panel specifically test the APP gene.

More info about this panel
Portugal.

Alzheimer disease types 1, 3 and 4 (sequence analysis of APP, PSEN1 and PSEN2 genes) Panel

Portugal.

By CGC Genetics Alzheimer disease types 1, 3 and 4 (sequence analysis of APP, PSEN1 and PSEN2 genes) that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
Portugal.

Cerebral amyloid angiopathy (sequence analysis of APP gene) Panel

Portugal.

By CGC Genetics

This panel specifically test the APP gene.

More info about this panel
Portugal.

Alzheimer disease type 1 (sequence analysis of exons 16 and 17 of APP gene) Panel

Portugal.

By CGC Genetics

This panel specifically test the APP gene.

More info about this panel
Portugal.

Alzheimer disease (NGS panel for 8 genes) Panel

Portugal.

By CGC Genetics Alzheimer disease (NGS panel for 8 genes) that also includes the following genes: SNCA SNCB SORL1 APOE APP PRNP PSEN1 PSEN2

More info about this panel
Portugal.

Hereditary dementias (NGS panel for 28 genes) Panel

Portugal.

By CGC Genetics Hereditary dementias (NGS panel for 28 genes) that also includes the following genes: SNCA SNCB SORL1 TARDBP TIMM8A TUBA4A TYROBP UBQLN2 VCP CHCHD10

More info about this panel
Portugal.

Alzheimer disease type 1, 3 e 4 (deletions/duplications analysis of APP, PSEN1 and PSEN2 genes) Panel

Portugal.

By CGC Genetics Alzheimer disease type 1, 3 e 4 (deletions/duplications analysis of APP, PSEN1 and PSEN2 genes) that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
Portugal.

Hereditary amyloidosis (NGS panel of 19 genes) Panel

Portugal.

By CGC Genetics Hereditary amyloidosis (NGS panel of 19 genes) that also includes the following genes: TACSTD2 TGFBI TNFRSF1A TTR NLRP3 IL31RA CST3 F10 FGA GSN

More info about this panel
Portugal.

Alzheimer disease type 1, 3 e 4 (deletions/duplications analysis of APP, PSEN1 and PSEN2 genes) Panel

Portugal.

By CGC Genetics Alzheimer disease type 1, 3 e 4 (deletions/duplications analysis of APP, PSEN1 and PSEN2 genes) that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
Portugal.

Hereditary amyloidosis (NGS panel of 19 genes) Panel

Portugal.

By CGC Genetics Hereditary amyloidosis (NGS panel of 19 genes) that also includes the following genes: TACSTD2 TGFBI TNFRSF1A TTR NLRP3 IL31RA CST3 F10 FGA GSN

More info about this panel
Portugal.

Alzheimer Disease, Familial or Cerebral Amyloid Angiopathy via APP Gene Sequencing with CNV Detection Panel

United States.

By PreventionGenetics PreventionGenetics

This panel specifically test the APP gene.

More info about this panel
United States.

Alzheimer Disease, Familial, Sequencing Panel with CNV Detection Panel

United States.

By PreventionGenetics PreventionGenetics Alzheimer Disease, Familial, Sequencing Panel with CNV Detection that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
United States.

Dementia Sequencing Panel with CNV Detection Panel

United States.

By PreventionGenetics PreventionGenetics Dementia Sequencing Panel with CNV Detection that also includes the following genes: SQSTM1 TARDBP TYROBP UBQLN2 TREM2 CHMP2B C9orf72 FUS GRN APP

More info about this panel
United States.

Parkinson Disease and Parkinsonism Sequencing Panel with CNV Detection Panel

United States.

By PreventionGenetics PreventionGenetics Parkinson Disease and Parkinsonism Sequencing Panel with CNV Detection that also includes the following genes: SLC20A2 SLC6A3 SNCA SNCB SPG11 SPR SYNJ1 TAF1 TARDBP TWNK

More info about this panel
United States.

Alzheimer Disease Type 1 Panel

Germany.

By MGZ Medical Genetics Center

This panel specifically test the APP gene.

More info about this panel
Germany.

Neurogenetic Disorders - panels Panel

Germany.

By MGZ Medical Genetics Center Neurogenetic Disorders - panels that also includes the following genes: BCS1L RTN2 RYR1 SACS SCN1A SCN1B SCN2A SCN8A SCO1 SCO2

More info about this panel
Germany.

Brain Malformations / Neuronal Migration Disorders Panel

Germany.

By MGZ Medical Genetics Center Brain Malformations / Neuronal Migration Disorders that also includes the following genes: RPL10 RPS6KA3 SCN1A SCN1B SCN2A SCN8A SGCE SGSH STIL SLC16A2

More info about this panel
Germany.

Alzheimer´s disease Panel

Czech Republic.

By DNA Diagnostics Laboratory University Hospital Ostrava Alzheimer´s disease that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
Czech Republic.

Alzheimer disease type 1 Panel

Germany.

By Centogene AG - the Rare Disease Company

This panel specifically test the APP gene.

More info about this panel
Germany.

Alzheimer dementia and dementia panel Panel

Germany.

By Centogene AG - the Rare Disease Company Alzheimer dementia and dementia panel that also includes the following genes: SORL1 TREM2 APOE APP PRNP PSEN1 PSEN2

More info about this panel
Germany.

AllNeuro panel Panel

Germany.

By Centogene AG - the Rare Disease Company AllNeuro panel that also includes the following genes: BCS1L ROR2 RPL10 BDNF RPS6KA3 RTN2 RYR1 SACS BIN1 SBF1

More info about this panel
Germany.

Alzheimer's disease Panel Panel

Germany.

By CeGaT GmbH Alzheimer's disease Panel that also includes the following genes: TBP VPS35 MARK4 NLGN1 CD33 TOMM40 ABCA7 APOE APP PSEN1

More info about this panel
Germany.

Dementia all Panel Panel

Germany.

By CeGaT GmbH Dementia all Panel that also includes the following genes: ATXN2 SQSTM1 TARDBP TBK1 TBP TUBA4A UBQLN2 VCP VPS35 MARK4

More info about this panel
Germany.

Single gene testing APP Panel

Germany.

By CeGaT GmbH

This panel specifically test the APP gene.

More info about this panel
Germany.

Alzheimer disease Panel

Poland.

By Laboratory of Human Genetics GENOMED Health Care Center Alzheimer disease that also includes the following genes: SORL1 TREM2 GRN APP PSEN1 PSEN2

More info about this panel
Poland.

Alzheimer Disease Type 1 (APP) Panel

Germany.

By MVZ Dortmund Dr. Eberhard & Partner

This panel specifically test the APP gene.

More info about this panel
Germany.

CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED Panel

Germany.

By MVZ Dortmund Dr. Eberhard & Partner

This panel specifically test the APP gene.

More info about this panel
Germany.

Alzheimer Disease Type 1 Panel

Germany.

By Labor-MVZ Westmecklenburg Laboratory for Molecular Diagnostics

This panel specifically test the APP gene.

More info about this panel
Germany.

Test for Alzheimer Disease Type 1 Panel

Spain.

By Secugen SL

This panel specifically test the APP gene.

More info about this panel
Spain.

Alzheimer Disease Type 1, Alzheimer Disease, Early-Onset Familial Panel

Germany.

By ATG-GenMed ATG-GenMed

This panel specifically test the APP gene.

More info about this panel
Germany.

qChip Panel

Spain.

By Quantitative Genomic Medicine Laboratories, SL qChip that also includes the following genes: RS1 RUNX2 SALL1 SCN1A BMPR1A SH2D1A SEM1 SHH SHOX SIM1

More info about this panel
Spain.

Invitae Hereditary Alzheimer's Disease Panel Panel

United States.

By Invitae Invitae Hereditary Alzheimer's Disease Panel that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
United States.

Invitae Combined Hereditary Dementia and Amyotrophic Lateral Sclerosis Panel Panel

United States.

By Invitae Invitae Combined Hereditary Dementia and Amyotrophic Lateral Sclerosis Panel that also includes the following genes: SNCA SOD1 SPG11 TARDBP TBK1 TFG UBQLN2 VAPB VCP CHCHD10

More info about this panel
United States.

Alzheimer: Apo-E, PSEN1, PSEN2, A2M and APP genes sequence analysis (select exons) Panel

Spain.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Alzheimer: Apo-E, PSEN1, PSEN2, A2M and APP genes sequence analysis (select exons) that also includes the following genes: APOE APP A2M PSEN1 PSEN2

More info about this panel
Spain.

Alzheimer: Apo-E, PSEN1, PSEN2, APP, A2M and MAPT genes sequence analysis (select exons) Panel

Spain.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Alzheimer: Apo-E, PSEN1, PSEN2, APP, A2M and MAPT genes sequence analysis (select exons) that also includes the following genes: APOE APP MAPT A2M PSEN1 PSEN2

More info about this panel
Spain.

APP: APP gene sequence analysis (exons 16-17) Panel

Spain.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases

This panel specifically test the APP gene.

More info about this panel
Spain.

NGS panel - dementia Panel

Netherlands.

By Genome Diagnostics VU University Medical Center NGS panel - dementia that also includes the following genes: SNCA SNCB SOD1 SORL1 SQSTM1 TARDBP TYROBP UBAP1 UBQLN2 VAPB

More info about this panel
Netherlands.

APP - Select Exon Sequencing (APP) Panel

Netherlands.

By Genome Diagnostics VU University Medical Center

This panel specifically test the APP gene.

More info about this panel
Netherlands.

Parkinson-Alzheimer-Dementia NGS Panel Panel

United States.

By Fulgent Genetics Fulgent Genetics Parkinson-Alzheimer-Dementia NGS Panel that also includes the following genes: SLC6A3 SNCA SNCB TAF1 TH TYROBP UCHL1 VPS35 FBXO7 AAAS

More info about this panel
United States.

Early Onset Familial Alzheimer Disease (EOFAD) NGS Panel Panel

United States.

By Fulgent Genetics Fulgent Genetics Early Onset Familial Alzheimer Disease (EOFAD) NGS Panel that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
United States.

APP Panel

United States.

By Fulgent Genetics Fulgent Genetics

This panel specifically test the APP gene.

More info about this panel
United States.

Dementia Panel Panel

Finland.

By Blueprint Genetics Dementia Panel that also includes the following genes: SNCA SORL1 TARDBP TUBA4A UBE3A UBQLN2 VCP TREM2 RNF216 CSF1R

More info about this panel
Finland.

Early-onset autosomal dominant Alzheimer disease Panel

Spain.

By Bioarray

This panel specifically test the APP gene.

More info about this panel
Spain.

Cerebral amyloid angiopathy, Panel

Spain.

By Bioarray

This panel specifically test the APP gene.

More info about this panel
Spain.

Cerebral Amyloid Angiopathy (APP gene) Panel

Belgium.

By Diagnostic Service Facility University of Antwerp

This panel specifically test the APP gene.

More info about this panel
Belgium.

Alzheimer Dementia (APP gene) Panel

Belgium.

By Diagnostic Service Facility University of Antwerp

This panel specifically test the APP gene.

More info about this panel
Belgium.

AMYLOIDOSIS HEREDITARY NGS PANEL Panel

Spain.

By Laboratorio de Genetica Clinica SL AMYLOIDOSIS HEREDITARY NGS PANEL that also includes the following genes: TACSTD2 TGFBI TNFRSF1A TTR NLRP3 IL31RA CST3 F10 FGA GSN

More info about this panel
Spain.

CEREBRAL AMYLOID ANGIOPATHY Panel

Spain.

By Laboratorio de Genetica Clinica SL

This panel specifically test the APP gene.

More info about this panel
Spain.

ALZHEIMER DISEASE, EARLY- ONSET FAMILIAL Panel

Spain.

By Laboratorio de Genetica Clinica SL ALZHEIMER DISEASE, EARLY- ONSET FAMILIAL that also includes the following genes: APP PSEN1 PSEN2

More info about this panel
Spain.

DEMENTIA & ALZHEIMER: NGS PANEL Panel

Spain.

By Laboratorio de Genetica Clinica SL DEMENTIA & ALZHEIMER: NGS PANEL that also includes the following genes: SORL1 TARDBP VCP TREM2 CSF1R CHMP2B FUS GRN APOE ITM2B

More info about this panel
Spain.

Alzheimer Disease, Sequencing APP Gene Panel

Spain.

By Reference Laboratory Genetics

This panel specifically test the APP gene.

More info about this panel
Spain.

Alzheimer Disease, Sequencing Exons (16,17) APP Gene Panel

Spain.

By Reference Laboratory Genetics

This panel specifically test the APP gene.

More info about this panel
Spain.

Alzheimer Disease, Deletions-Duplications (MLPA) APP Gene Panel

Spain.

By Reference Laboratory Genetics

This panel specifically test the APP gene.

More info about this panel
Spain.

Alzheimer Disease, Panel Massive Sequencing (NGS) 8 Genes Panel

Spain.

By Reference Laboratory Genetics Alzheimer Disease, Panel Massive Sequencing (NGS) 8 Genes that also includes the following genes: C9orf72 GRN APOE APP MAPT A2M PSEN1 PSEN2

More info about this panel
Spain.

Familial Alzheimer Disease Panel

Germany.

By Labor Dr. Wisplinghoff Familial Alzheimer Disease that also includes the following genes: APOE APP PSEN1

More info about this panel
Germany.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like HJV FDXR TUBB8 SLC16A1 DSE